JATT II Acquisition Corp.
Status: Live Deal
U=S
| IPO Proceeds, $M | $60.00M |
|---|---|
| IPO Date | Apr 17, 2026 |
| CEO | Dr. Someit Sidhu |
| Left Lead | Guggenheim Securities |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector | Healthcare ▶ |
| IPO Geography | Global |
| Target Company | Talawar Therapeutics |
| Deal Announced | Jun 29, 2026 |
| Deal Size, $M | $120.00M |
| Deal Sector | Healthcare |
| Deal Geography | Global |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | TBD |
| Amendment Vote | TBD |
JATT
| Price | $11.69 |
|---|---|
| Last closing price | $12.21 |
| H/L, today | $12.00 / $12.36 |
| Volume, today | 59,231 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.